Kintor Pharma sets Hong Kong IPO in motion

Jonathan Breen

May 12, 2020 06:45 am

pills adobe stock 575x375 pharmaceuticals — Heap of medical pills in white, blue and other colors. Pills in plastic package. Panoramic banner for design. | OKSANA KAZYKINA/okskaz - stock.adobe.com

China-based Kintor Pharmaceutical has kicked off bookbuilding for its Hong Kong listing, the latest in a stream of healthcare IPOs in the city. The issuer is targeting HK$1.86bn ($240.1m) in proceeds.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Health and Biotech UBS Equity China Merchants Bank Co China China International Capital Corp Hong Kong SAR Asia Coronavirus Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets SRI

JB

Jonathan Breen

Equities editor GlobalCapital Asia